Nanotechnology Now







Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > NanoImaging Services Relocates to Larger Facility in La Jolla, Calif.

Abstract:
Biopharmaceutical analytical services company expands into a 2,500 square-foot laboratory and adds staff to accommodate growing business

NanoImaging Services Relocates to Larger Facility in La Jolla, Calif.

San Diego, CA | Posted on March 22nd, 2008

NanoImaging Services, Inc., the leading provider of high-resolution, three-dimensional (3D) transmission electron microscope (TEM) imaging services to manufacturers of large molecule biopharmaceuticals, announced today that it has moved to a larger facility in La Jolla, Calif. The new 2,500-square-foot facility will enable NanoImaging Services to expand the capacity of its service laboratory and add new employees in an effort to accommodate its growing biopharmaceutical client base.

"By allowing researchers to actually see the nano scale structures they are working with, we help them improve speed and reduce risk in all phases of the drug development process, from discovery and characterization through approval and manufacturing," said Clint Potter, CEO, NanoImaging Services. "This new facility will allow us to meet the rapidly growing demand we have seen already in our first four months of operation."

NanoImaging benefited from early support and funding from Merck Capital Ventures, LLC, a subsidiary of Merck & Co., Inc., and FEI Company. The company's new location is 10931 North Torrey Pines Road, # 108, San Diego, CA 92037 USA. For more information, please visit www.nanoimagingservices.com.

####

About NanoImaging Services, Inc.
NanoImaging Services, Inc. provides transmission electron microscope imaging services to the pharmaceutical, biotechnology and nanotechnology industries, and specializes in the characterization of large biological molecules used in biopharmaceuticals such as vaccines, antibodies, cytokines, hormones and gene therapies. In contrast to conventional (small molecule) drugs, biopharmaceuticals are typically protein-based and manufactured in controlled, modified, biological systems. Their complexity and similarity to naturally occurring compounds makes a detailed understanding of their structure, and its relationship to their safety and efficacy, essential in their development and approval. Biopharmaceuticals represent an important and rapidly-growing segment of the pharmaceutical industry.

For more information, please click here

Contacts:
Clint Potter
NanoImaging Services, Inc.
888-675-8261


Sandy Fewkes
MindWrite Communications, Inc.
408-224-4024

Copyright © NanoImaging Services, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Rutgers, NIST physicists report technology with potential for sub-micron optical switches March 31st, 2015

Prototype 'nanoneedles' generate new blood vessels in mice: Scientists have developed tiny 'nanoneedles' that have successfully prompted parts of the body to generate new blood vessels, in a trial in mice March 31st, 2015

Super sensitive measurement of magnetic fields March 31st, 2015

Nanomedicine pioneer Mauro Ferrari at ETH Zurich March 31st, 2015

Imaging

'Atomic chicken-wire' is key to faster DNA sequencing March 30th, 2015

FEI Technology Award of the German Neuroscience Society Goes to Benjamin Judkewitz of the University of Berlin: Bi-annual award honors excellence in brain research during the German Neuroscience Society’s Annual Meeting, held 18-21 March 2015 March 26th, 2015

Square ice filling for a graphene sandwich March 26th, 2015

Openings/New facilities/Groundbreaking/Expansion

DFG to Establish One Clinical Research Unit and Five Research Units: New Projects to Investigate Complications in Pregnancy, Particle Physics, Nanoparticles, Implants and Transport Planning / Approximately 13 Million Euros in Funding for an Initial Three-Year Period March 28th, 2015

Haydale Announce Dedicated Graphene Inks Manufacturing Capability March 25th, 2015

Announcements

Rutgers, NIST physicists report technology with potential for sub-micron optical switches March 31st, 2015

Prototype 'nanoneedles' generate new blood vessels in mice: Scientists have developed tiny 'nanoneedles' that have successfully prompted parts of the body to generate new blood vessels, in a trial in mice March 31st, 2015

Super sensitive measurement of magnetic fields March 31st, 2015

Nanomedicine pioneer Mauro Ferrari at ETH Zurich March 31st, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2015 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE